| Literature DB >> 23428180 |
Elisa Majounie1, William Cross, Victoria Newsway, Allissa Dillman, Jana Vandrovcova, Christopher M Morris, Michael A Nalls, Luigi Ferrucci, Michael J Owen, Michael C O'Donovan, Mark R Cookson, Andrew B Singleton, Rohan de Silva, Huw R Morris.
Abstract
Progressive supranuclear palsy (PSP) is the most common atypical parkinsonian disorder. Abnormal tau inclusions, in selected regions of the brain, are a hallmark of the disease and the H1 haplotype of MAPT, the gene encoding tau, is the major risk factor in PSP. A 3-repeat and 4-repeat (4R) tau isoform ratio imbalance has been strongly implicated as a cause of disease. Thus, understanding tau isoform regional expression in disease and pathology-free states is crucial to elucidating the mechanisms involved in PSP and other tauopathies. We used a tau isoform-specific fluorescent assay to investigate relative 4R-tau expression in 6 different brain regions in PSP cases and healthy control samples. We identified a marked difference in 4R-tau relative expression, across brain regions and between MAPT haplotypes. Highest 4R-tau expression levels were identified in the globus pallidus compared with pons, cerebellum, and frontal cortex. 4R-tau expression levels were related to the MAPT H1 and H1c haplotypes. Similar regional variation was seen in PSP case and in control samples.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23428180 PMCID: PMC3642280 DOI: 10.1016/j.neurobiolaging.2013.01.017
Source DB: PubMed Journal: Neurobiol Aging ISSN: 0197-4580 Impact factor: 4.673